Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: COMPARISON OF MRD-MARKERS USING MUTATION-SPECIFIC DDPCR IN BONE MARROW AND PERIPHERAL BLOOD AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MDS

JSON

Lindholm C, Tobiasson M, Pandzic T, Illman J, Nilsson L, Weström S, Ejerblad E, Olesen G, Björklund A, Kittang AO, Werlenius O, Wiggh J, Lorentz F, Rasmussen B, Cammenga J, Weber D, Moen AE, Lundström LY, Bahr LV, Dimitriou M, Kytölä S, Walldin G, Ljungman P, Groenbaek K, Mielke S, Jacobsen SE, Ebeling F, Cavelier L, Friis LS, Dybedal I, Hellstrom-Lindberg E

Leuk. Res. 128 (-) 107227 [2023-05-00; online 2023-05-00]

DOI 10.1016/j.leukres.2023.107227

Crossref 10.1016/j.leukres.2023.107227